ADC Therapeutics Q4 Earnings Preview
Source: SeekingAlpha
2026-03-09 10:26:53 ET
More on ADC Therapeutics
- ADC Therapeutics SA (ADCT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- ADC Therapeutics posts preliminary 2025 revenue of about $73M
- Seeking Alpha’s Quant Rating on ADC Therapeutics
- Historical earnings data for ADC Therapeutics
- Financial information for ADC Therapeutics
Read the full article on Seeking Alpha
For further details see:
ADC Therapeutics Q4 Earnings Preview
ADC Therapeutics SA
NASDAQ: ADCT
ADCT Trading
1.71% G/L:
$4.16 Last:
163,004 Volume:
$4.03 Open:
ADCT Latest News
March 10, 2026 07:30:00 am
ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update
ADCT Stock Data
$486,217,661
104,923,913
12.45%
40
N/A
Biotechnology & Life Sciences
Healthcare
CH
Epalinges
